4 Einträge gefunden

1. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials

   1. Simpson, Eric L
   2. Merola, Joseph F
   3. Silverberg, Jonathan I
   4. Reich, Kristian
   5. Warren, Richard B
   6. Staumont-Sallé, Delphine
   7. Girolomoni, Giampiero

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results

   1. Silverberg, Jonathan I
   2. de Bruin-Weller, Marjolein
   3. Bieber, Thomas
   4. Soong, Weily
   5. Kabashima, Kenji
   6. Costanzo, Antonio
   7. Rosmarin, David

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

   1. Reich, Kristian
   2. Teixeira, Henrique D
   3. de Bruin-Weller, Marjolein
   4. Bieber, Thomas
   5. Soong, Weily
   6. Kabashima, Kenji
   7. Werfel, Thomas

   2021 - Forschungsinformationssystem des UKE
4. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

   1. Deleuran, Mette
   2. Thaçi, Diamant
   3. Beck, Lisa A
   4. de Bruin-Weller, Marjolein
   5. Blauvelt, Andrew
   6. Forman, Seth
   7. Bissonnette, Robert

   2020 - Forschungsinformationssystem des UKE